Learn More
The 2009 pandemic influenza A virus outbreak led to the systematic use of the neuraminidase (NA) inhibitor oseltamivir (OST). Consequently, OST-resistant strains, carrying the mutation H275Y, emerged(More)
The 2009 pandemic influenza A (H1N1) virus (pH1N1) challenged the world's preparedness to this threat (Dawood et al., 2009). Since this novel virus emerged with adamantane resistance, neuraminidase(More)
  • 1